CLINICAL_TRIALS trial_result · 2025-02-21

Clinical Trial Update: IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up

This update reports on a completed study examining IDH1/2 mutational analysis in patients with Acute Myeloid Leukemia to aid diagnosis and follow-up.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Josep Carreras Leukaemia Research Institute | Conditions: Acute Myeloid Leukemia | Status: COMPLETED